Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Atherosclerosis

• Publication date

  1989-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0021-9150(89)90228-1PMID 2571335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034.

  1989cited by this paper
• Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.

  1988cited by this paper
• In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue.

  1988cited by this paper
• Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis?

  1987cited by this paper
• Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.

  1987cited by this paper
• Estradiol protects against experimental cardiac transplant atherosclerosis.

  1987cited by this paper
• Estradiol protects against experimental cardiac transplant atherosclerosis.

  1987cited by this paper
• Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells.

  1987cited by this paper
• Cardiac transplant atherosclerosis.

  1987cited by this paper
• 2-Amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam.

  1986cited by this paper
• Expression of Ia and the production of interleukin 1 by peritoneal exudate macrophages activated in vivo by steroids.

  1986cited by this paper
• Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

  1985cited by this paper
• Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts.

  1984cited by this paper
• Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse.

  1984cited by this paper
• Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia.

  1977cited by this paper
• Morphologic Findings in Human Cardiac Allografts

  1970cited by this paper

• Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model

  2017cites this paper
• Chronic Allograft Nephropathy (Chronic Allograft Damage): Can It Be Avoided?

  2014cites this paper
• Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty

  2012cites this paper
• Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty

  2012cites this paper
• An artificial nanoemulsion carrying paclitaxel decreases the transplant heart vascular disease: a study in a rabbit graft model.

  2011cites this paper
• A novel computer-based method for the measurement of the lipid "load" in the coronary vessels of rabbits.

  2007cites this paper
• Preclinical Investigation of Agents Used in Current Restenosis Trials Preclinical Animal Mechanism of Animal and in vitro data model injury findings Platelet receptor and mediator inhibitors GR 32191 Yes Rat Balloon injury Platelet inhibition I Intimal hyperplasia * Sulotroban No

  2005cites this paper
• H9c2 cardiac muscle cells express all somatostatin receptor subtypes

  2004cites this paper
• Immunosuppression and transplant vascular disease: benefits and adverse effects.

  2003cites this paper
• Opportunities in somatostatin research: biological, chemical and therapeutic aspects

  2003cites this paper
• Short-term angiopeptin therapy and the incidence of graft vessel disease after heart transplantation.

  2002cites this paper
• The effects of magnesium sulphate and EDTA in the hypercholesterolaemic rabbit

  2001cites this paper
• Gene therapy of transplant arteriopathy by liposome-mediated transfection of endothelial nitric oxide synthase.

  2000cites this paper
• Coronary vasospasm associated with uncontrolled carcinoid tumour

  2000cites this paper
• Somatostatin receptor subtype expression and function in human vascular tissue.

  2000cites this paper
• Novel approaches for the prevention of restenosis

  2000cites this paper
• Effect of endothelial and adventitial injury on somatostatin receptor expression.

  2000cites this paper
• Are there markers to initiate treatment of chronic rejection?

  1999cites this paper
• Estrogens and octapeptides in rejection

  1999cites this paper
• Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts.

  1999cites this paper
• Development of atherosclerotic lesions in cholesterol-loaded rabbits.

  1999cites this paper
• Effect of angiopeptin and aspirin on accelerated graft atherosclerosis in transplanted mouse heart.

  1999cites this paper
• Do calcium channel blockers and HMG-CoA reductase inhibitors attenuate allograft arteriopathy?

  1998cites this paper
• Effects of octreotide in patients with hypertrophic obstructive cardiomyopathy.

  1998cites this paper
• Differential effects of somatostatin and angiopeptin on cell proliferation

  1998cites this paper
• Postischemic reperfusion injury and allograft arteriosclerosis.

  1998cites this paper
• Current experience with somatostatin analogues, especially angiopeptine, for the prevention of transplant vasculopathy in heart transplantation.

  1998cites this paper
• The role of lipids in transplant vascular disease.

  1998cites this paper
• Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.

  1997cites this paper
• Direct effects of somatostatin analog octreotide on insulin-like growth factor-I in the arterial wall.

  1997cites this paper
• Restenosis: is there a pharmacologic fix in the pipeline?

  1997cites this paper
• Endogenous Expression Modification: Antisense Approaches

  1997cites this paper
• Transplantation atherosclerosis: Definition and pathogenesis

  1997cites this paper
• Acceleration of arteriosclerosis of the rat aorta allograft by insulin growth factor-I.

  1997cites this paper
• Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells

  1997cites this paper
• Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.

  1997cites this paper
• The role of inflammation in the development of allograft coronary disease.

  1997cites this paper
• HMG-CoA reductase inhibitors in organ transplantation.

  1997cites this paper
• Graft vascular disease after heart transplantation.

  1997cites this paper
• Angiopeptin induces beneficial vascular remodeling after balloon injury.

  1997cites this paper
• Angiopeptin inhibits thymidine incorporation by explants of porcine coronary arteries.

  1997cites this paper
• Pharmacologic control of smooth muscle cells in allografts.

  1997cites this paper
• Transplantation atherosclerosis

  1996cites this paper
• Blockade of growth factor synthesis and growth factor action: two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury.

  1996cites this paper
• Chronic rejection and late renal allograft dysfunction

  1996cites this paper
• Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.

  1996cites this paper
• Diagnosis and Management of Cardiac Allograft Vasculopathy (Chronic Rejection)

  1996cites this paper
• Angiopeptin--an immunological review.

  1996cites this paper
• Chronic rejection: potential new sites of therapy.

  1996cites this paper
• Experimental models of accelerated atherosclerosis syndromes.

  1996cites this paper
• Chronic allograft rejection.

  1996cites this paper
• Graft coronary vasculopathy in cardiac transplantation--evaluation of risk factors by multivariate analysis.

  1996cites this paper
• Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.

  1996cites this paper
• Estrogen and prevention of transplant atherosclerosis.

  1995cites this paper
• New developments in the diagnosis and management of cardiac allograft vasculopathy.

  1995cites this paper
• Effects of angiopeptin on transplant arteriosclerosis in the rat

  1995cites this paper
• A new somatostatin analog inhibits neointima formation induced by balloon injury in rats without altering growth hormone release

  1995cites this paper
• Cardiac allograft vasculopathy: current concepts.

  1995cites this paper
• Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts.

  1995cites this paper
• LEW-to-F344 carotid artery allografts: analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses.

  1995cites this paper
• Relevance of Smooth Muscle Replication and Development to Vascular Disease

  1995cites this paper
• A new somatostatin analog with optimized ring size inhibits neointima formation induced by balloon injury in rats without altering growth hormone release

  1995cites this paper
• Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty.

  1995cites this paper
• Angiopeptin, a somatostatin-14 analogue, decreases adhesiveness of rat leukocytes to unstimulated and IL-1 beta-activated rat heart endothelial cells.

  1995cites this paper
• Angiopeptin (BIM23014C) Inhibits Vascular Smooth Muscle Cell Migration In Vitro Through a G‐Protein-Mediated Pathway and Is Associated with Inhibition of Adenylyl Cyclase and Cyclic AMP Accumulation

  1995cites this paper
• Stimulation of hepatic insulin-like growth factor-binding protein-1 and -3 gene expression by octreotide in rats.

  1995cites this paper
• The Intima: Soil for Atherosclerosis and Restenosis

  1995cites this paper
• Growth hormone and insulin-like growth factor-I: a suggested role in renal transplantation and graft vessel disease.

  1995cites this paper
• Experimental therapeutics and clinical studies in (re)stenosis.

  1995cites this paper
• Estradiol inhibition of arterial neointimal hyperplasia after balloon injury.

  1994cites this paper
• Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability.

  1994cites this paper
• Early inhibition of myointimal proliferation by angiopeptin after balloon catheter injury in the rabbit.

  1994cites this paper
• Involvement of Growth Factors in Pseudointimal Hyperplasia, Analyzed by Synthetic Somatostatin Analogues

  1994cites this paper
• Murine model of accelerated transplant arteriosclerosis.

  1994cites this paper
• Metabolic factors and outcome of organ transplantation.

  1994cites this paper
• Dose-dependent stimulation of insulin-like growth factor-binding protein-1 by lanreotide, a somatostatin analog.

  1994cites this paper
• CHRONIC REJECTION IN THE RAT AORTIC ALLOGRAFT: V. MECHANISM OF THE ANGIOPEPTIN (BIM23014C) EFFECT ON THE GENERATION OF ALLOGRAFT ARTERIOSCLEROSIS

  1993cites this paper
• Animal models of chronic heart and kidney allograft rejection.

  1993cites this paper
• The Effect of Porous Infusion Balloon‐Delivered Angiopeptin on Myointimal Hyperplasia After Balloon Injury in the Rabbit

  1993cites this paper
• Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection.

  1993cites this paper
• Angiopeptin Inhibits Intimal Hyperplasia After Angioplast in Porcine Coronary Arteries

  1993cites this paper
• Rat heart smooth muscle cells express high and low affinity receptors for somatostatin-14, which are involved in regulation of cell proliferation.

  1993cites this paper
• Somatostatin analog Lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis

  1993cites this paper
• Angiopeptin inhibition of myointimal hyperplasia after balloon angioplasty of large arteries in hypercholesterolaemic rabbits.

  1993cites this paper
• Pathogenesis and Treatment Perspectives of Chronic Graft Rejection (CVR)

  1993cites this paper
• Chronic Allograft Rejection

  1993cites this paper
• Accelerated cardiac transplant atherosclerosis/chronic rejection in rabbits: inhibition by angiopeptin.

  1993cites this paper
• Leukocyte-endothelium interaction as a target for antiatherogenic strategies in allograft transplantation.

  1993cites this paper
• Chronic allograft rejection.

  1993cites this paper
• Chronic Graft Rejection: Accelerated Transplant Arteriosclerosis

  1993cites this paper
• Immune mechanisms of cardiac allograft vasculopathy: an update.

  1993cites this paper
• Impact of ischemia time on chronic vascular rejection in the rat--effects of angiopeptin.

  1993cites this paper
• MODULATORS OF CHRONIC REJECTION

  1993cites this paper
• Pathophysiology of vascular wall changes in chronic allograft rejection

  1993cites this paper
• Chronic vascular rejection of the heart and the kidney--have rational treatment options emerged?

  1992cites this paper
• Coronary Angioplast in Cardiac Transplant Patients: Results of a Multicenter Study

  1992cites this paper
• Coronary angioplasty in cardiac transplant patients. Results of a multicenter study.

  1992cites this paper
• The rabbit: An underestimated model for the study of chronic allograft rejection

  1992cites this paper
• Inhibition of intimal hyperplasia by photodynamic therapy using photofrin.

  1992cites this paper
• Experimental models of coronary artery restenosis.

  1992cites this paper